{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:50:16Z","timestamp":1790167816819,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T00:00:00Z","timestamp":1594684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T00:00:00Z","timestamp":1594684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Operational Programme \u201cCompetitiveness, Entrepreneurship and Innovation\u201d","award":["MIS 5002691"],"award-info":[{"award-number":["MIS 5002691"]}]},{"name":"Operational Programme \u201cCompetitiveness, Entrepreneurship and Innovation\u201d","award":["MIS 5002550"],"award-info":[{"award-number":["MIS 5002550"]}]},{"DOI":"10.13039\/100000008","name":"Operational Programme \"Competitiveness, Entrepreneurship and Innovation\"","doi-asserted-by":"publisher","award":["MIS 5002755"],"award-info":[{"award-number":["MIS 5002755"]}],"id":[{"id":"10.13039\/100000008","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001674","name":"Fondation Leducq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001674","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s00018-020-03583-y","type":"journal-article","created":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T11:03:40Z","timestamp":1594724620000},"page":"1523-1544","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Structure\u2013function analysis of naturally occurring apolipoprotein A-I L144R, A164S and L178P mutants provides insight on their role on HDL levels and cardiovascular risk"],"prefix":"10.1007","volume":"78","author":[{"given":"Christina","family":"Gkolfinopoulou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faye","family":"Soukou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Dafnis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahsin F.","family":"Kellici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Despina","family":"Sanoudou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Mavromoustakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efstratios","family":"Stratikos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3107-1189","authenticated-orcid":false,"given":"Angeliki","family":"Chroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,14]]},"reference":[{"key":"3583_CR1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/978-3-319-09665-0_2","volume":"224","author":"VI Zannis","year":"2015","unstructured":"Zannis VI, Fotakis P, Koukos G, Kardassis D, Ehnholm C, Jauhiainen M, Chroni A (2015) HDL biogenesis, remodeling, and catabolism. Handb Exp Pharmacol 224:53\u2013111","journal-title":"Handb Exp Pharmacol"},{"key":"3583_CR2","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/HCO.0000000000000211","volume":"30","author":"HK Siddiqi","year":"2015","unstructured":"Siddiqi HK, Kiss D, Rader D (2015) HDL-cholesterol and cardiovascular disease: rethinking our approach. Curr Opin Cardiol 30:536\u2013542","journal-title":"Curr Opin Cardiol"},{"key":"3583_CR3","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1126\/science.271.5248.518","volume":"271","author":"S Acton","year":"1996","unstructured":"Acton S, Rigotti A, Landschulz KT, Xu S, Hobbs HH, Krieger M (1996) Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 271:518\u2013520","journal-title":"Science"},{"key":"3583_CR4","doi-asserted-by":"crossref","first-page":"e67993","DOI":"10.1371\/journal.pone.0067993","volume":"8","author":"G Daniil","year":"2013","unstructured":"Daniil G, Zannis VI, Chroni A (2013) Effect of apoA-I mutations in the capacity of reconstituted HDL to promote ABCG1-mediated cholesterol efflux. PLoS One 8:e67993","journal-title":"PLoS One"},{"key":"3583_CR5","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1161\/CIRCRESAHA.111.258673","volume":"111","author":"C Mineo","year":"2012","unstructured":"Mineo C, Shaul PW (2012) Novel biological functions of high-density lipoprotein cholesterol. Circ Res 111:1079\u20131090","journal-title":"Circ Res"},{"key":"3583_CR6","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00392-017-1106-1","volume":"106","author":"W Marz","year":"2017","unstructured":"Marz W, Kleber ME, Scharnagl H, Speer T, Zewinger S, Ritsch A, Parhofer KG et al (2017) HDL cholesterol: reappraisal of its clinical relevance. Clin Res Cardiol 106:663\u2013675","journal-title":"Clin Res Cardiol"},{"key":"3583_CR7","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/FJC.0000000000000573","volume":"71","author":"E Favari","year":"2018","unstructured":"Favari E, Thomas MJ, Sorci-Thomas MG (2018) High-density lipoprotein functionality as a new pharmacological target on cardiovascular disease: unifying mechanism that explains high-density lipoprotein protection toward the progression of atherosclerosis. J Cardiovasc Pharmacol 71:325\u2013331","journal-title":"J Cardiovasc Pharmacol"},{"key":"3583_CR8","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/nsmb.3501","volume":"24","author":"JT Melchior","year":"2017","unstructured":"Melchior JT, Walker RG, Cooke AL, Morris J, Castleberry M, Thompson TB, Jones MK et al (2017) A consensus model of human apolipoprotein A-I in its monomeric and lipid-free state. Nat Struct Mol Biol 24:1093\u20131099","journal-title":"Nat Struct Mol Biol"},{"key":"3583_CR9","doi-asserted-by":"crossref","first-page":"38570","DOI":"10.1074\/jbc.M111.260422","volume":"286","author":"X Mei","year":"2011","unstructured":"Mei X, Atkinson D (2011) Crystal structure of C-terminal truncated apolipoprotein A-I reveals the assembly of high density lipoprotein (HDL) by dimerization. J Biol Chem 286:38570\u201338582","journal-title":"J Biol Chem"},{"key":"3583_CR10","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.arcmed.2015.05.012","volume":"46","author":"X Mei","year":"2015","unstructured":"Mei X, Atkinson D (2015) Lipid-free apolipoprotein A-I structure: insights into HDL formation and atherosclerosis development. Arch Med Res 46:351\u2013360","journal-title":"Arch Med Res"},{"key":"3583_CR11","doi-asserted-by":"crossref","first-page":"12291","DOI":"10.1073\/pnas.94.23.12291","volume":"94","author":"DW Borhani","year":"1997","unstructured":"Borhani DW, Rogers DP, Engler JA, Brouillette CG (1997) Crystal structure of truncated human apolipoprotein A-I suggests a lipid-bound conformation. Proc Natl Acad Sci USA 94:12291\u201312296","journal-title":"Proc Natl Acad Sci USA"},{"key":"3583_CR12","doi-asserted-by":"crossref","first-page":"12176","DOI":"10.1073\/pnas.0803626105","volume":"105","author":"RA Silva","year":"2008","unstructured":"Silva RA, Huang R, Morris J, Fang J, Gracheva EO, Ren G, Kontush A et al (2008) Structure of apolipoprotein A-I in spherical high density lipoproteins of different sizes. Proc Natl Acad Sci USA 105:12176\u201312181","journal-title":"Proc Natl Acad Sci USA"},{"key":"3583_CR13","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/nsmb.2028","volume":"18","author":"R Huang","year":"2011","unstructured":"Huang R, Silva RA, Jerome WG, Kontush A, Chapman MJ, Curtiss LK, Hodges TJ et al (2011) Apolipoprotein A-I structural organization in high-density lipoproteins isolated from human plasma. Nat Struct Mol Biol 18:416\u2013422","journal-title":"Nat Struct Mol Biol"},{"key":"3583_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jmb.2012.09.027","volume":"425","author":"O Gursky","year":"2013","unstructured":"Gursky O (2013) Crystal structure of Delta(185-243)ApoA-I suggests a mechanistic framework for the protein adaptation to the changing lipid load in good cholesterol: from flatland to sphereland via double belt, belt buckle, double hairpin and trefoil\/tetrafoil. J Mol Biol 425:1\u201316","journal-title":"J Mol Biol"},{"key":"3583_CR15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1050-1738(01)00163-3","volume":"12","author":"MG Sorci-Thomas","year":"2002","unstructured":"Sorci-Thomas MG, Thomas MJ (2002) The effects of altered apolipoprotein A-I structure on plasma HDL concentration. Trends Cardiovasc Med 12:121\u2013128","journal-title":"Trends Cardiovasc Med"},{"key":"3583_CR16","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s00109-005-0030-4","volume":"84","author":"VI Zannis","year":"2006","unstructured":"Zannis VI, Chroni A, Krieger M (2006) Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL. J Mol Med 84:276\u2013294","journal-title":"J Mol Med"},{"key":"3583_CR17","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.2174\/0929867325666180313114950","volume":"26","author":"A Chroni","year":"2019","unstructured":"Chroni A, Kardassis D (2019) HDL dysfunction caused by mutations in apoA-I and other genes that are critical for HDL biogenesis and remodeling. Curr Med Chem 26:1544\u20131575","journal-title":"Curr Med Chem"},{"key":"3583_CR18","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1365-2796.2011.02381.x","volume":"270","author":"CL Haase","year":"2011","unstructured":"Haase CL, Frikke-Schmidt R, Nordestgaard BG, Kateifides AK, Kardassis D, Nielsen LB, Andersen CB et al (2011) Mutation in APOA1 predicts increased risk of ischaemic heart disease and total mortality without low HDL cholesterol levels. J Intern Med 270:136\u2013146","journal-title":"J Intern Med"},{"key":"3583_CR19","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0021-9150(01)00753-5","volume":"163","author":"D Recalde","year":"2002","unstructured":"Recalde D, Cenarro A, Garcia-Otin AL, Gomez-Coronado D, Civeira F, Pocovi M (2002) Analysis of apolipoprotein A-I, lecithin:cholesterol acyltransferase and glucocerebrosidase genes in hypoalphalipoproteinemia. Atherosclerosis 163:49\u201358","journal-title":"Atherosclerosis"},{"key":"3583_CR20","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.jacc.2004.06.070","volume":"44","author":"GK Hovingh","year":"2004","unstructured":"Hovingh GK, Brownlie A, Bisoendial RJ, Dube MP, Levels JH, Petersen W, Dullaart RP et al (2004) A novel apoA-I mutation (L178P) leads to endothelial dysfunction, increased arterial wall thickness, and premature coronary artery disease. J Am Coll Cardiol 44:1429\u20131435","journal-title":"J Am Coll Cardiol"},{"key":"3583_CR21","doi-asserted-by":"crossref","first-page":"158593","DOI":"10.1016\/j.bbalip.2019.158593","volume":"1865","author":"C Gkolfinopoulou","year":"2020","unstructured":"Gkolfinopoulou C, Bourtsala A, Chroni A (2020) Structural and functional basis for increased HDL-cholesterol levels due to the naturally occurring V19L mutation in human apolipoprotein A-I. Biochim Biophys Acta Mol Cell Biol Lipids 1865:158593","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"3583_CR22","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.pep.2011.06.011","volume":"79","author":"L Argyri","year":"2011","unstructured":"Argyri L, Skamnaki V, Stratikos E, Chroni A (2011) A simple approach for human recombinant apolipoprotein E4 expression and purification. Protein Expr Purif 79:251\u2013257","journal-title":"Protein Expr Purif"},{"key":"3583_CR23","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1194\/jlr.M043489","volume":"54","author":"P Fotakis","year":"2013","unstructured":"Fotakis P, Tiniakou I, Kateifides AK, Gkolfinopoulou C, Chroni A, Stratikos E, Zannis VI et al (2013) Significance of the hydrophobic residues 225\u2013230 of apoA-I for the biogenesis of HDL. J Lipid Res 54:3293\u20133302","journal-title":"J Lipid Res"},{"key":"3583_CR24","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1021\/bi00731a008","volume":"12","author":"JD Morrisett","year":"1973","unstructured":"Morrisett JD, David JS, Pownall HJ, Gotto AM Jr (1973) Interaction of an apolipoprotein (apoLP-alanine) with phosphatidylcholine. Biochemistry 12:1290\u20131299","journal-title":"Biochemistry"},{"key":"3583_CR25","doi-asserted-by":"crossref","first-page":"15910","DOI":"10.1021\/bi0014406","volume":"39","author":"IN Gorshkova","year":"2000","unstructured":"Gorshkova IN, Liadaki K, Gursky O, Atkinson D, Zannis VI (2000) Probing the lipid-free structure and stability of apolipoprotein A-I by mutation. Biochemistry 39:15910\u201315919","journal-title":"Biochemistry"},{"key":"3583_CR26","doi-asserted-by":"crossref","first-page":"6719","DOI":"10.1074\/jbc.M205232200","volume":"278","author":"A Chroni","year":"2003","unstructured":"Chroni A, Liu T, Gorshkova I, Kan HY, Uehara Y, von Eckardstein A, Zannis VI (2003) The central helices of apoA-I can promote ATP-binding cassette transporter A1 (ABCA1)-mediated lipid efflux. Amino acid residues 220-231 of the wild-type apoA-I are required for lipid efflux in vitro and high density lipoprotein formation in vivo. J Biol Chem 278:6719\u20136730","journal-title":"J Biol Chem"},{"key":"3583_CR27","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1042\/BCJ20180068","volume":"475","author":"I Dafnis","year":"2018","unstructured":"Dafnis I, Raftopoulou C, Mountaki C, Megalou E, Zannis VI, Chroni A (2018) ApoE isoforms and carboxyl-terminal-truncated apoE4 forms affect neuronal BACE1 levels and Abeta production independently of their cholesterol efflux capacity. Biochem J 475:1839\u20131859","journal-title":"Biochem J"},{"key":"3583_CR28","doi-asserted-by":"crossref","first-page":"e45660","DOI":"10.1371\/journal.pone.0045660","volume":"7","author":"AC Chadwick","year":"2012","unstructured":"Chadwick AC, Sahoo D (2012) Functional characterization of newly-discovered mutations in human SR-BI. PLoS One 7:e45660","journal-title":"PLoS One"},{"key":"3583_CR29","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/S0022-2275(20)33491-X","volume":"40","author":"G Lambert","year":"1999","unstructured":"Lambert G, Chase MB, Dugi K, Bensadoun A, Brewer HB Jr, Santamarina-Fojo S (1999) Hepatic lipase promotes the selective uptake of high density lipoprotein-cholesteryl esters via the scavenger receptor B1. J Lipid Res 40:1294\u20131303","journal-title":"J Lipid Res"},{"key":"3583_CR30","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1074\/jbc.M607831200","volume":"282","author":"WS Kim","year":"2007","unstructured":"Kim WS, Rahmanto AS, Kamili A, Rye KA, Guillemin GJ, Gelissen IC, Jessup W et al (2007) Role of ABCG1 and ABCA1 in regulation of neuronal cholesterol efflux to apolipoprotein E discs and suppression of amyloid-beta peptide generation. J Biol Chem 282:2851\u20132861","journal-title":"J Biol Chem"},{"key":"3583_CR31","doi-asserted-by":"crossref","first-page":"10442","DOI":"10.1021\/bi049782p","volume":"43","author":"A Chroni","year":"2004","unstructured":"Chroni A, Kan HY, Kypreos KE, Gorshkova IN, Shkodrani A, Zannis VI (2004) Substitutions of glutamate 110 and 111 in the middle helix 4 of human apolipoprotein A-I (apoA-I) by alanine affect the structure and in vitro functions of apoA-I and induce severe hypertriglyceridemia in apoA-I-deficient mice. Biochemistry 43:10442\u201310457","journal-title":"Biochemistry"},{"key":"3583_CR32","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1161\/01.RES.0000199272.59432.5b","volume":"98","author":"D Seetharam","year":"2006","unstructured":"Seetharam D, Mineo C, Gormley AK, Gibson LL, Vongpatanasin W, Chambliss KL, Hahner LD et al (2006) High-density lipoprotein promotes endothelial cell migration and reendothelialization via scavenger receptor-B type I. Circ Res 98:63\u201372","journal-title":"Circ Res"},{"key":"3583_CR33","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1161\/CIRCULATIONAHA.113.001720","volume":"128","author":"F Jansen","year":"2013","unstructured":"Jansen F, Yang X, Hoelscher M, Cattelan A, Schmitz T, Proebsting S, Wenzel D et al (2013) Endothelial microparticle-mediated transfer of MicroRNA-126 promotes vascular endothelial cell repair via SPRED1 and is abrogated in glucose-damaged endothelial microparticles. Circulation 128:2026\u20132038","journal-title":"Circulation"},{"key":"3583_CR34","first-page":"36","volume":"11","author":"MD Abramoff","year":"2004","unstructured":"Abramoff MD, Magelhaes PJ, Ram SJ (2004) Image processing with ImageJ. Biophotonics Int 11:36\u201342","journal-title":"Biophotonics Int"},{"key":"3583_CR35","doi-asserted-by":"crossref","first-page":"30654","DOI":"10.1038\/srep30654","volume":"6","author":"I Dafnis","year":"2016","unstructured":"Dafnis I, Argyri L, Sagnou M, Tzinia A, Tsilibary EC, Stratikos E, Chroni A (2016) The ability of apolipoprotein E fragments to promote intraneuronal accumulation of amyloid beta peptide 42 is both isoform and size-specific. Sci Rep 6:30654","journal-title":"Sci Rep"},{"key":"3583_CR36","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1073\/pnas.93.7.2991","volume":"93","author":"O Gursky","year":"1996","unstructured":"Gursky O, Atkinson D (1996) Thermal unfolding of human high-density apolipoprotein A-1: implications for a lipid-free molten globular state. Proc Natl Acad Sci USA 93:2991\u20132995","journal-title":"Proc Natl Acad Sci USA"},{"key":"3583_CR37","doi-asserted-by":"crossref","first-page":"e0120233","DOI":"10.1371\/journal.pone.0120233","volume":"10","author":"X Zhang","year":"2015","unstructured":"Zhang X, Lei D, Zhang L, Rames M, Zhang S (2015) A model of lipid-free apolipoprotein A-I revealed by iterative molecular dynamics simulation. PLoS One 10:e0120233","journal-title":"PLoS One"},{"key":"3583_CR38","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1021\/bi051669r","volume":"45","author":"IN Gorshkova","year":"2006","unstructured":"Gorshkova IN, Liu T, Kan HY, Chroni A, Zannis VI, Atkinson D (2006) Structure and stability of apolipoprotein A-I in solution and in discoidal high-density lipoprotein probed by double charge ablation and deletion mutation. Biochemistry 45:1242\u20131254","journal-title":"Biochemistry"},{"key":"3583_CR39","doi-asserted-by":"crossref","first-page":"28634","DOI":"10.1074\/jbc.M003407200","volume":"275","author":"AE Bortnick","year":"2000","unstructured":"Bortnick AE, Rothblat GH, Stoudt G, Hoppe KL, Royer LJ, McNeish J, Francone OL (2000) The correlation of ATP-binding cassette 1 mRNA levels with cholesterol efflux from various cell lines. J Biol Chem 275:28634\u201328640","journal-title":"J Biol Chem"},{"key":"3583_CR40","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1161\/01.ATV.0000148706.15947.8a","volume":"24","author":"E Favari","year":"2004","unstructured":"Favari E, Zanotti I, Zimetti F, Ronda N, Bernini F, Rothblat GH (2004) Probucol inhibits ABCA1-mediated cellular lipid efflux. Arterioscler Thromb Vasc Biol 24:2345\u20132350","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3583_CR41","first-page":"659","volume":"45","author":"A Hafiane","year":"2015","unstructured":"Hafiane A, Genest J (2015) HDL-mediated cellular cholesterol efflux assay method. Ann Clin Lab Sci 45:659\u2013668","journal-title":"Ann Clin Lab Sci"},{"key":"3583_CR42","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/emmm.201200224","volume":"4","author":"C Besler","year":"2012","unstructured":"Besler C, Luscher TF, Landmesser U (2012) Molecular mechanisms of vascular effects of High-density lipoprotein: alterations in cardiovascular disease. EMBO Mol Med 4:251\u2013268","journal-title":"EMBO Mol Med"},{"key":"3583_CR43","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1172\/JCI35470","volume":"118","author":"N Terasaka","year":"2008","unstructured":"Terasaka N, Yu S, Yvan-Charvet L, Wang N, Mzhavia N, Langlois R, Pagler T et al (2008) ABCG1 and HDL protect against endothelial dysfunction in mice fed a high-cholesterol diet. J Clin Investig 118:3701\u20133713","journal-title":"J Clin Investig"},{"key":"3583_CR44","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1172\/JCI42946","volume":"121","author":"C Besler","year":"2011","unstructured":"Besler C, Heinrich K, Rohrer L, Doerries C, Riwanto M, Shih DM, Chroni A et al (2011) Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease. J Clin Investig 121:2693\u20132708","journal-title":"J Clin Investig"},{"key":"3583_CR45","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/jbt.21588","volume":"28","author":"VS Soumyarani","year":"2014","unstructured":"Soumyarani VS, Jayakumari N (2014) Oxidized HDL induces cytotoxic effects: implications for atherogenic mechanism. J Biochem Mol Toxicol 28:481\u2013489","journal-title":"J Biochem Mol Toxicol"},{"key":"3583_CR46","doi-asserted-by":"crossref","first-page":"E1051","DOI":"10.3390\/ijms20051051","volume":"20","author":"Z Solati","year":"2019","unstructured":"Solati Z, Ravandi A (2019) Lipidomics of bioactive lipids in acute coronary syndromes. Int J Mol Sci 20:E1051","journal-title":"Int J Mol Sci"},{"key":"3583_CR47","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0021-9150(00)00555-4","volume":"154","author":"D Recalde","year":"2001","unstructured":"Recalde D, Velez-Carrasco W, Civeira F, Cenarro A, Gomez-Coronado D, Ordovas JM, Pocovi M (2001) Enhanced fractional catabolic rate of apo A-I and apo A-II in heterozygous subjects for apo A-I(Zaragoza) (L144R). Atherosclerosis 154:613\u2013623","journal-title":"Atherosclerosis"},{"key":"3583_CR48","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.cca.2011.03.011","volume":"412","author":"G Daniil","year":"2011","unstructured":"Daniil G, Phedonos AA, Holleboom AG, Motazacker MM, Argyri L, Kuivenhoven JA, Chroni A (2011) Characterization of antioxidant\/anti-inflammatory properties and apoA-I-containing subpopulations of HDL from family subjects with monogenic low HDL disorders. Clin Chim Acta 412:1213\u20131220","journal-title":"Clin Chim Acta"},{"key":"3583_CR49","doi-asserted-by":"crossref","first-page":"e0143915","DOI":"10.1371\/journal.pone.0143915","volume":"10","author":"J Dalla-Riva","year":"2015","unstructured":"Dalla-Riva J, Lagerstedt JO, Petrlova J (2015) Structural and functional analysis of the apolipoprotein A-I A164S variant. PLoS One 10:e0143915","journal-title":"PLoS One"},{"key":"3583_CR50","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1172\/JCI23858","volume":"115","author":"C Assanasen","year":"2005","unstructured":"Assanasen C, Mineo C, Seetharam D, Yuhanna IS, Marcel YL, Connelly MA, Williams DL et al (2005) Cholesterol binding, efflux, and a PDZ-interacting domain of scavenger receptor-BI mediate HDL-initiated signaling. J Clin Investig 115:969\u2013977","journal-title":"J Clin Investig"},{"key":"3583_CR51","doi-asserted-by":"crossref","first-page":"6525","DOI":"10.1096\/fj.201800248RR","volume":"32","author":"Y Shi","year":"2018","unstructured":"Shi Y, Lv X, Liu Y, Li B, Liu M, Yan M, Liu Y et al (2018) Elevating ATP-binding cassette transporter G1 improves re-endothelialization function of endothelial progenitor cells via Lyn\/Akt\/eNOS in diabetic mice. FASEB J 32:6525\u20136536","journal-title":"FASEB J"},{"key":"3583_CR52","first-page":"1095","volume":"15","author":"G Marsche","year":"2001","unstructured":"Marsche G, Levak-Frank S, Quehenberger O, Heller R, Sattler W, Malle E (2001) Identification of the human analog of SR-BI and LOX-1 as receptors for hypochlorite-modified high density lipoprotein on human umbilical venous endothelial cells. FASEB J 15:1095\u20131097","journal-title":"FASEB J"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-020-03583-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-020-03583-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-020-03583-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T23:49:22Z","timestamp":1626220162000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-020-03583-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,14]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["3583"],"URL":"https:\/\/doi.org\/10.1007\/s00018-020-03583-y","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,14]]},"assertion":[{"value":"20 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}